KAREN J WILSON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KAREN J WILSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KAREN J WILSON. KAREN J WILSON is a Director in Vaxart, Inc. ($VXRT) and a Vice President, CFO in Monogram Biosciences, Inc. ($VLGC) and a SVP, Finance & PAO in Jazz Pharmaceuticals plc ($JAZZ) and a Director in Angion Biomedica Corp. ($ANG).
Address: C/O VIROLOGIC, INC. 345 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which KAREN J WILSON is an Insider
Angion Biomedica Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KAREN J WILSON: Director
Holdings: 18,718 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KAREN J WILSON: SVP, Finance & PAO
Holdings: 18,687 shares
Current Value: $2,336,809
Latest Transaction: Mar 07 2019
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Monogram Biosciences, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of KAREN J WILSON: Vice President, CFO
Holdings: 0 shares
Latest Transaction: Mar 25 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vaxart, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KAREN J WILSON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 27 2020
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KAREN J WILSON
Sentiment: All, ANG, JAZZ, VLGC, VXRT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | ANG | Angion Biomedica C ... | WILSON KAREN J | Director | Option Exercise | A | 15.01 | 15,000 | 225,150 | 15,000 | |
| Feb 11 2021 | ANG | Angion Biomedica C ... | WILSON KAREN J | Director | Buy | C | 11.57 | 18,718 | 216,567 | 18,718 | 0 to 18.7 K |
| Aug 27 2020 | VXRT | Vaxart, Inc. | WILSON KAREN J | Director | Option Exercise | A | 6.95 | 65,700 | 456,615 | 65,700 | |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 135.82 | 302 | 41,018 | 18,385 | 18.7 K to 18.4 K (-1.62 %) |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 135.82 | 276 | 37,486 | 18,687 | 19 K to 18.7 K (-1.46 %) |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.03 | 8,174 | 1,144,605 | 8,174 | |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.03 | 576 | 80,657 | 576 |